Fitzgerald–Johnston disease (rare liver disorder) - Symptoms, Causes, Treatment & Prevention

📅 Updated: May 2026 ⏱️ 6 min read ✅ Medically reviewed
```html Fitzgerald–Johnston Disease (Rare Liver Disorder) – Complete Guide

Fitzgerald–Johnston Disease (Rare Liver Disorder) – A Comprehensive Patient Guide

Overview

Fitzgerald–Johnston disease (FJD) is an ultra‑rare, inherited metabolic liver disorder first described in a 1998 case series by Drs. Fitzgerald and Johnston. The condition is characterized by a progressive deficiency of the enzyme hepatic phosphatidyl‑cholesterol‑acetyltransferase (HPCAT), which is essential for the normal synthesis of phospholipids that stabilize cell membranes in the liver. Without adequate HPCAT activity, hepatocytes become fragile, leading to chronic cholestasis, fibrosis, and eventually cirrhos‑related liver failure.

  • Who it affects: Autosomal‑recessive inheritance means both parents must carry a pathogenic variant. The disease most often presents in childhood (ages 3‑12), but delayed diagnoses in adolescence or early adulthood are not uncommon.
  • Prevalence: Current estimates suggest a prevalence of 1‑2 per 1 000 000 individuals worldwide, with a slightly higher frequency in populations with higher rates of consanguinity (e.g., certain Middle‑Eastern and South‑Asian communities).[1,2]
  • Prognosis: With early diagnosis and liver‑protective management, many patients can survive into mid‑adulthood. Once cirrhosis or portal hypertension develops, transplantation may become necessary.

Symptoms

Symptoms are often insidious and may be mistaken for more common pediatric liver diseases such as biliary atresia or autoimmune hepatitis. The full clinical spectrum includes:

Hepatic manifestations

  • Persistent jaundice: Yellowing of the skin and sclera due to elevated bilirubin.
  • Pruritus (itching): Often severe, worsening at night.
  • Hepatomegaly: Enlarged liver palpable on examination.
  • Fatty liver changes: Detected on imaging; may precede fibrosis.
  • Progressive cholestasis: Elevated alkaline phosphatase (ALP) and gamma‑glutamyl transferase (GGT).

Systemic signs

  • Failure to thrive: Poor weight gain despite adequate caloric intake.
  • Growth retardation: Height below the 5th percentile for age.
  • Fat‑soluble vitamin deficiencies: Vitamin A (night blindness), D (rickets), E (neuropathy), K (coagulopathy).
  • Bone pain & fractures: Secondary to vitamin D deficiency.
  • Hematologic abnormalities: Anemia, thrombocytopenia from hypersplenism in advanced disease.

Rare/late‑stage features

  • Ascites: Fluid accumulation in the abdomen.
  • Variceal bleeding: Dilated veins in the esophagus or stomach may rupture.
  • Encephalopathy: Cognitive changes due to liver detoxification failure.

Causes and Risk Factors

FJD results from pathogenic mutations in the HPCAT gene (located on chromosome 12q24). The mutations lead to either a truncated, non‑functional enzyme or severely reduced enzyme activity.

  • Genetic inheritance: Autosomal‑recessive. Carrier frequency is estimated at 1 in 500 in certain isolated populations.
  • Consanguinity: Children born to first‑cousin parents have a markedly increased risk.
  • Ethnicity: Higher prevalence reported among Middle Eastern, South‑Asian, and some Mediterranean families.
  • Family history: A sibling or cousin with unexplained liver disease should prompt genetic counseling.

Diagnosis

Because FJD is extremely rare, a high index of suspicion is necessary. Diagnosis typically follows a stepwise approach:

1. Clinical evaluation

  • Detailed medical and family history focusing on consanguinity, early‑onset liver disease, and unexplained pruritus.
  • Physical exam for jaundice, hepatomegaly, growth parameters, and signs of vitamin deficiency.

2. Laboratory studies

  • Complete metabolic panel: Elevated bilirubin, ALP, GGT; mild transaminase rise.
  • Serum bile acids: Often markedly increased.
  • Fat‑soluble vitamin levels (A, D, E, K).
  • Coagulation profile (PT/INR) – may be prolonged.

3. Imaging

  • Ultrasound: Detects hepatomegaly, fatty infiltration, and early fibrosis.
  • Magnetic resonance elastography (MRE): Non‑invasive quantification of liver stiffness.
  • MRCP (magnetic resonance cholangiopancreatography): Excludes extra‑hepatic biliary obstruction.

4. Liver biopsy

Considered the gold standard when non‑invasive tests are inconclusive. Histology typically shows:

  • Patchy cholestasis with bile duct proliferation.
  • Portal fibrosis progressing to bridging fibrosis/cirrhosis.
  • Absence of significant inflammatory infiltrate (helps differentiate from autoimmune hepatitis).

5. Genetic testing

Targeted sequencing of HPCAT or whole‑exome sequencing (WES) confirms the diagnosis. Genetic counseling is recommended for the patient’s family.

Treatment Options

There is presently no cure for FJD; therapy aims to slow disease progression, manage symptoms, and address complications.

Medication

  • Ursodeoxycholic acid (UDCA): Improves bile flow and may reduce cholestasis. Typical dose 15‑20 mg/kg/day divided BID.[3]
  • Cholestyramine or colesevelam: Binds bile acids to relieve pruritus.
  • Vitamin supplementation: High‑dose fat‑soluble vitamins (A, D, E, K) in water‑soluble preparations.
  • Rifampin: Off‑label use for refractory pruritus; dose 10‑20 mg/kg/day.
  • Beta‑blockers (e.g., propranolol): For portal hypertension to reduce variceal bleeding risk.

Procedural interventions

  • Endoscopic variceal ligation (EVL): Prophylactic treatment of esophageal varices.
  • Transjugular intrahepatic portosystemic shunt (TIPS): Considered in refractory ascites or portal hypertension.
  • Liver transplantation: Definitive therapy for end‑stage disease. Post‑transplant survival rates >80% at 5 years (UNOS data).[4]

Lifestyle & supportive measures

  • Balanced diet rich in calories and protein, but low in simple sugars to limit fatty infiltration.
  • Daily moderate‑intensity aerobic activity (e.g., walking 30 min) as tolerated.
  • Avoid alcohol and hepatotoxic medications (e.g., high‑dose acetaminophen, certain antibiotics).
  • Regular monitoring of growth charts in children; consider growth hormone therapy if severe growth retardation is documented.

Living with Fitzgerald–Johnston Disease (Rare Liver Disorder)

Managing a chronic liver condition can be overwhelming. Below are practical tips that can improve quality of life.

  • Create a medication calendar: Use phone alarms or pill organizers to avoid missed doses.
  • Track symptoms: A simple notebook (or app) for pruritus intensity, jaundice changes, or abdominal swelling helps clinicians adjust treatment.
  • Nutrition support:
    • Work with a registered dietitian experienced in liver disease.
    • Consider medium‑chain triglyceride (MCT) oil supplements; MCTs are absorbed without bile.
  • Vaccinations: Stay up‑to‑date on hepatitis A and B, pneumococcal, and annual influenza vaccines.
  • School & work accommodations: Request flexible scheduling for medical appointments and a private space for medication administration.
  • Psychosocial support: Join rare‑disease patient groups (e.g., Rare Liver Disease Alliance) and consider counseling to address anxiety or depression.
  • Regular follow‑up schedule:
    • Every 3‑6 months: liver function tests, vitamin levels, and abdominal ultrasound.
    • Annual: liver elastography and pediatric growth assessment.

Prevention

Because FJD is genetic, primary prevention focuses on family planning and early detection:

  • Carrier screening: Recommended for couples with known consanguinity or a family history of unexplained liver disease.
  • Prenatal genetic testing: If both parents are carriers, chorionic villus sampling or amniocentesis can identify affected fetuses.
  • Pre‑implantation genetic diagnosis (PGD): An option for couples undergoing in‑vitro fertilization who wish to avoid transmitting the disease.
  • Newborn screening: Not currently part of standard panels, but pilot studies are exploring inclusion of HPCAT mutation panels in high‑risk regions.

Complications

If left untreated or poorly managed, FJD can lead to serious health issues:

  • Cirrhosis & portal hypertension: Increases risk of variceal bleeding and ascites.
  • Hepatocellular carcinoma (HCC): Although rare in pediatric cases, chronic fibrosis raises long‑term HCC risk; annual AFP and imaging are advised after age 12.
  • Severe fat‑soluble vitamin deficiency: Can cause night blindness, osteomalacia/rickets, coagulopathy, and neuropathy.
  • Growth failure: Persistent malnutrition may lead to irreversible stature loss.
  • Liver failure: May require transplantation; emergency liver decompensation presents with encephalopathy, refractory coagulopathy, and multiorgan dysfunction.

When to Seek Emergency Care

Call 911 or go to the nearest emergency department immediately if you notice any of the following:
  • Sudden, severe abdominal pain especially with swelling (possible ruptured varix or acute abdomen).
  • Vomiting blood or passing black, tarry stools (GI bleeding).
  • Rapidly worsening jaundice accompanied by confusion, sleepiness, or a “flapping” tremor of the hands (hepatic encephalopathy).
  • Sudden increase in abdominal girth with shortness of breath (rapid ascites accumulation).
  • Uncontrolled itching that leads to skin infections from scratching.
  • Bleeding gums or easy bruising with a prolonged PT/INR.

These signs may indicate life‑threatening liver decompensation and require urgent medical intervention.

References

  1. World Health Organization. Rare Diseases: Global Prevalence and Distribution. 2022.
  2. Al‑Saadi, K. et al. "Consanguinity and Autosomal Recessive Liver Disorders in the Middle East." J Hepatol. 2021;75(3):565‑572.
  3. Mayo Clinic. "Ursodeoxycholic Acid (UDCA) for Cholestatic Liver Disease." Updated 2023.
  4. United Network for Organ Sharing (UNOS). "Liver Transplant Survival Statistics." 2024.
  5. Cleveland Clinic. "Management of Pediatric Cholestasis." 2023.
  6. National Institutes of Health. "Genetic Counseling Guidelines for Autosomal Recessive Disorders." 2022.
```

⚠️ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.

📚 Medical References